Commercial Space Company Risk / Opportunity Ranking

Thesis: The reviewed sources only gives contextual membership rationale that Emposat provides ground-station access used in connection with a surveillance satellite, which is too indirect to support a durable positive investment thesis without direct within the recent evidence window business evidence.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat.

Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard.

Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, despite membership rationale describing EnduroSat as a space infrastructure and satellite-constellation builder.

Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here.

Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment.

Thesis: No positive thesis is supportable from the scoring evidence fields because no direct positive evidence are provided.

Why now: Why now is stronger than for most names here because the phase2 rationale specifically ties EON Space Labs to a PSLV failure context via article: implying a concrete event rather than generic company context. However, conviction remains low because the reviewed sources omits the underlying event summary and dates in the evidence exposed here.

Caveats: The adverse signal appears only in phase2 rationale, not in direct negative evidence. No article summary, quote, or timing detail is provided in the scoring fields. Impact magnitude on EON specifically cannot be quantified from these reviewed sources alone.

Thesis: The reviewed sources' membership rationale says FOSSA Systems has launched 24 satellites, is deploying an 80-satellite constellation, and has defense customers, but there are no available direct positive evidence or dated representative articles within the reviewed sources for scoring, so opportunity remains only a watchlist possibility.

Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources.

Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale.

Thesis: The company belongs in the cohort as an Earth observation / SAR startup, but these reviewed sources provide no available within the recent evidence window directional evidence to support a strong 1 year+ opportunity thesis.

Why now: There is no within the recent evidence window evidence available for this entity in the reviewed sources; recency of any business progress is uncertain.

Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff for this entity. Membership rationale references article IDs, and: but no article summaries or direct evidence are included in these reviewed sources for citation-level use. Scores are constrained by absence of directional evidence, not by a proven negative business outcome.

Thesis: No reviewed sources-supported positive thesis is available. The company is only described as appearing in generic 'space stocks' context, while direct positive evidence after the 90-day recent evidence window is absent.

Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported.

Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement.

Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a positive 1 year+ opportunity thesis.

Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources.

Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them.

Thesis: The reviewed sources offers no direct positive company-specific evidence within the available scoring set. The membership rationale says Hensoldt appears in a market report as one of many key players in the space situational awareness market, but that is article-level market-list context rather than direct business evidence, and no available evidence remain after recent evidence window.

Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact.

Thesis: A limited positive angle exists because the membership rationale says a HEO camera achieved sub-5-meter resolution in Sidus Space's earnings context, implying technical relevance (: and: unavailable in reviewed sources). However, this appears indirect and counterparty/component context rather than direct company evidence, so opportunity remains low.

Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence.

Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window.

Thesis: No direct positive evidence is available. The reviewed sources say Hermeus is only mentioned as one of several companies expanding in California in an article about Skydio, which is too indirect to support a durable positive thesis.

Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available.

Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context.

Thesis: The reviewed sources places HughesNet within satellite broadband and communication services context via EchoStar, but there is no direct reviewed evidence in the 90-day window to support a differentiated 1 year+ opportunity thesis.

Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible.

Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources.

Thesis: There is no direct positive evidence in the available scoring set. The reviewed sources say Impulso is mentioned only as GalaxEye's distribution agreement counterparty, which does not establish Impulso's own business opportunity.

Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis.

Thesis: Potential long-horizon opportunity exists if the previously referenced multi-launch agreement for servicing satellites remains active, but the reviewed sources provide no retained within the recent evidence window positive evidence to support a current thesis.

Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established.

Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence.

Thesis: No current positive thesis is supportable within the reviewed sources' retained recent evidence window evidence.

Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026).

Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale.

Thesis: No positive thesis can be supported from retained evidence because the reviewed sources contain no direct positive rows within the recent evidence window.

Why now: No current catalyst is evidenced in retained rows.

Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence.

Thesis: No positive thesis can be supported because there is no retained direct positive evidence within the reviewed sources' recent evidence window.

Why now: No current business change or catalyst is evidenced in the retained rows.

Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing.

Thesis: No admissible direct positive evidence was available inside the 90-day recent evidence window, so there is no supportable positive 1 year+ opportunity thesis from these reviewed sources alone.

Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources.

Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources.

Thesis: Kepler may have long-horizon potential because the membership rationale says it operates an optical relay satellite network and is prime contractor on ESA HydRON optical communications work, but there is no available within the recent evidence window evidence in these reviewed sources to substantiate a directional score.

Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company.

Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain.

Thesis: Reviewed evidence hints only that Kessler Dynamics was listed in a spacetech accelerator with themes including rocket propulsion, satellites, and space energy, but no in-recent evidence window direct evidence or article is provided, so there is no supported positive thesis.

Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation.

Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule.

Thesis: No direct positive evidence is available, so there is no supportable opportunity thesis from these reviewed sources alone.

Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering.

Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources.

Thesis: Main risk is execution and evidence uncertainty rather than a documented adverse event. The reviewed sources only provides undated supporting article context about a seed round and intended use of proceeds, which leaves recency, funding durability, and commercialization progress uncertain.

Why now: Why now is weak because the only support is undated context articles; the reviewed sources explicitly says no is available, so recency-sensitive claims should be treated cautiously for these funding and expansion statements

Caveats: Evidence is undated; recency is uncertain. Support is supporting article context only, not direct structured positive event evidence. Same funding story appears in two articles and should not be treated as independent confirmation.

Thesis: The reviewed sources provide no retained article or evidence after recent evidence window to quantify contract size, award stage, revenue timing, or execution burden, so the opportunity is plausible but not well-validated and downside cannot be measured.

Why now: The reviewed sources provide no post-recent evidence window detailed evidence, but the membership rationale specifically references selection for the Andromeda program via article. Because the underlying article summary/ is not included here, timing and magnitude are uncertain.

Caveats: No representative article or is included for the cited Andromeda selection evidence. Selection for a program is positive, but without award size or timing the business impact is unclear. Scores are capped by missing direct article-level support.

Thesis: Risk is slightly higher than base because the company is described only through older membership rationale involving development of the Terran R reusable rocket and financing participation, without current evidence confirming execution progress, but this remains low-conviction because no direct negative evidence is retained.

Why now: Why now is weak because there are no retained post-cutoff article summaries or evidence in the reviewed sources.

Caveats: No retained evidence after recent evidence window. The modest risk uplift reflects uncertainty from lack of current confirmation, not a direct adverse event.

Thesis: There is also strategy-execution risk because the phase-2 rationale says the project is early stage with no final timeline or finalized investment, but again the reviewed sources does not provide retained article-level citations for those statements here, so risk remains low-scored due to weak grounding.

Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0.

Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view.

Thesis: The reviewed sources supports some development-stage and timing risk because the cited milestone is still a planned future demonstration mission in 2027, but the evidence is old and sparse.

Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis.

Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited.

Thesis: Risk is mostly uncertainty from missing current evidence rather than explicit adverse developments. Without available direct evidence, it is hard to assess whether financing, product progress, or customer conversion remains on track.

Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested.

Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence.

Thesis: As an apparent pre-launch rocket company, execution risk may be elevated, but the reviewed sources does not provide retained adverse evidence, so only a modest evidence-light risk score is justified.

Why now: No retained article or event evidence remains after recent evidence filtering; the only hint is a membership rationale referencing first test-launch focus via article: without an included summary.

Caveats: Cannot treat membership rationale alone as strong directional proof. No article summary or retained evidence row is included for article

Thesis: The same contextual pivot language also creates execution and qualification risk because the reviewed sources does not firmly establish Rocket One as a current operating space company in the target categories, and there is no direct post-recent evidence window evidence of contracts, product milestones, financing, or customer traction.

Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering.

Thesis: No material adverse evidence is available in the reviewed sources for RTX, so there is no supported risk thesis from the provided evidence.

Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence.

Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence.

Thesis: No material adverse evidence is available, but there is also no current direct evidence to establish momentum or deterioration.

Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence.

Thesis: No direct adverse evidence is available, but lack of current evidence means the reviewed sources cannot support a strong opportunity or risk thesis.

Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone.

Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence.

Thesis: The main risk is evidentiary: no direct adverse evidence is available, but there is also no in-window evidence confirming current execution, funding status, customer traction, or program progress, limiting confidence in any opportunity case.

Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis.

Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only.

Thesis: Main risk is evidence opacity rather than explicit adverse business events: the reviewed sources show 47 articles considered but zero article IDs after recent evidence window and zero evidence available after dedupe, leaving business-state recency uncertain.

Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus.

Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard.

Thesis: The reviewed sources show no direct adverse evidence. Main risk is that the available evidence is supporting article context rather than a fuller company-specific contract filing, and one related transportation agreement is older than the recent evidence window.

Why now: The key evidence is recent and within the recent evidence window: a June 11, 2026 SpaceNews article says SES was selected last month as a prime contractor under the PTS-G program, with K2 Space providing SES's satellite platform

Caveats: Reviewed evidence is still supporting article context rather than a direct company filing. The Impulse transportation agreement is older and outside the 90-day recent evidence window.

Thesis: The main risk is evidentiary rather than operational: the reviewed sources itself says mapping between Sierra Nevada Corporation and Sierra Space is not fully explicit, and the surviving support is supporting article context rather than direct company events.

Why now: The key surviving context is dated April 8, 2026, within the 90-day recent evidence window, and references recent contract awards under Andromeda that could matter over a 1 year+ horizon if they convert into meaningful program work. Article timestamp: April 8, 2026, basis: source date. Evidence is from at

Caveats: Evidence is supporting article context, not a direct structured positive event row for Sierra Nevada Corporation. Reviewed evidence explicitly notes entity-resolution ambiguity between Sierra Nevada Corporation and Sierra Space. The second representative article is older than the 90-day recent evidence window and should not drive recency, published September 2, 2025.

Thesis: Risk is mainly thesis slippage risk: the company may be an enabling software layer rather than a direct space operator, and the reviewed sources contain no direct business traction or adverse evidence for ranking.

Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon.

Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence.

Thesis: Risk is mainly execution and information opacity risk because the reviewed sources lack direct dated rows on revenue, contracts, milestones, or setbacks.

Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary.

Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence.

Thesis: The same evidence is weak for timing because it is undated supporting article context rather than direct event/fact evidence, so current economic significance and sequencing are uncertain

Why now: This is one of the only companies in the screen with any current evidence surviving the recent evidence window, but it is undated supporting context, so why-now confidence is still limited

Caveats: Evidence is undated and supporting article context only. Same article appears in multiple weak-context rows and is not independent confirmation. No direct positive event/fact beyond supporting context.

Thesis: Risk is primarily uncertainty and execution risk because no direct positive or negative rows are preserved in the ranking reviewed sources despite the membership rationale referencing funding and technology progress.

Why now: Why now is weak because the reviewed sources cites articles: and: in the membership rationale, but no or reviewed evidence are provided for ranking-grade citation.

Caveats: No article are provided for the referenced support articles. Cannot convert broad space-tech relevance into a strong opportunity thesis without direct evidence. Coverage after recent evidence window is empty.

Thesis: Primary risk in this ranking is stale evidence: there is no retained within the recent evidence window evidence to confirm current contracts, fleet expansion, or demand. That makes the near-current business state uncertain in these reviewed sources.

Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here.

Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis.